Anti-cancer and anti-angiogenesis effect of the leaf extract of Sargassum wightii against osteosarcoma cancer cells

Authors

  • Qi-Long Yu Department of Orthopedics, The Second People's Hospital of Weifang, Shandong 261041, China
  • Zhao-Chun Tang Department of Orthopedics, The Second People's Hospital of Weifang, Shandong 261041, China
  • Jin-Ge Li Department of Orthopedics, The Second People's Hospital of Weifang, Shandong 261041, China
  • Guo-Liang Wang Department of Orthopedics, The Second People's Hospital of Weifang, Shandong 261041, China
  • Pei-Jun Wang Department of Orthopedics, The Second People's Hospital of Weifang, Shandong 261041, China
  • Zhao-Bao Pan Department of Laboratory, The Second People's Hospital of Weifang, Shandong 261041, China

DOI:

https://doi.org/10.3329/bjp.v10i2.22473

Keywords:

Anti-angiogenesis, Anti-cancer, Osteosarcoma cancer cell, Sargassum wightii

Abstract

This study was aimed to evaluate the chemical composition of ethanolic leaf extract of a marine macro-alga Sargassum wightii (ELESW) followed by its vascular endothelial growth factor (VEGF) induced anti-angiogenic effect against human umbilical vein endothelial cells (HUVECs). The effect of ELESW on cell viability and its potential against in vivo angiogenesis was assessed by using the MTT and CAM assay respectively. The phenolic, flavonoid, polysaccharides, and protein content of ELESW were found to be 56.0 ± 4.1 mg GAE/g, 26.3 ± 3.6 mg QE/g, 284.2 ± 6.2, 100.9 ± 8.9 ?g/mL, respectively. In angiogenesis, ELESW (100, 500 and 1,000 ?g/mL) significantly inhibited VEGF induced angiogenesis as well as VEGF-induced proliferation and tube formation of HUVECs in a dose-dependent manner. Upon stimulition by VEGF, HUVECs rapidly increased reactive oxygen species production, which was significantly blocked by treatment with ELESW. These findings suggesting that S. wightii could be a valuable candidate of therapeutic efficacy.  

Downloads

Download data is not yet available.
Abstract
430
Download
308 Read
183

Downloads

Additional Files

Published

2015-04-20

How to Cite

Yu, Q.-L., Z.-C. Tang, J.-G. Li, G.-L. Wang, P.-J. Wang, and Z.-B. Pan. “Anti-Cancer and Anti-Angiogenesis Effect of the Leaf Extract of Sargassum Wightii Against Osteosarcoma Cancer Cells”. Bangladesh Journal of Pharmacology, vol. 10, no. 2, Apr. 2015, pp. 351-7, doi:10.3329/bjp.v10i2.22473.

Issue

Vol. 10 No. 2 (2015)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).